Neonatal herpes disease following maternal antenatal antiviral suppressive therapy

A multicenter case series

Swetha G Pinninti, Radhika Angara, Kristina N. Feja, David W. Kimberlin, Charles T. Leach, Dennis A. Conrad, Carol A. McCarthy, Robert W. Tolan

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Objective: The goal was to describe herpes simplex virus (HSV) disease in neonates whose mothers received suppressive acyclovir therapy for HSV infection. Study design: A multicenter case series of 8 infants who developed neonatal HSV disease following maternal antiviral suppressive therapy during pregnancy. Results: Eight infants were identified from New Jersey (5), Maine (1), New York (1), and Texas (1) between 2005 and 2009. All 6 mothers of infants infected with HSV who were screened prenatally for group B Streptococcus were positive; 1 mother was not tested and the other had bacterial vaginosis and genital human papillomavirus infection. Six mothers had a first clinical episode of genital HSV infection during this pregnancy; mothers with a prior history of genital HSV had no clinically recognized outbreak during the pregnancy. Perinatal transmission of HSV occurred in 7 infants (despite suppressive therapy until the day of delivery in 5 instances). Seven of 8 patients were born at term; 6 infants were male. In 7 of 8 cases, HSV was diagnosed by 8 days of age. Five infants had skin, eye, and mucous membrane disease, 2 had central nervous system disease (without and with disseminated disease), and one had intrauterine/disseminated disease. Conclusions: Although maternal antiviral suppressive therapy is an increasingly wide practice, physicians caring for neonates should be aware that suppressive therapy does not prevent neonatal HSV disease, which can have an atypical clinical presentation and drug resistance.

Original languageEnglish (US)
JournalJournal of Pediatrics
Volume161
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

Infant, Newborn, Diseases
Simplexvirus
Antiviral Agents
Mothers
Virus Diseases
Herpes Genitalis
Therapeutics
Pregnancy
Newborn Infant
Bacterial Vaginosis
Streptococcus agalactiae
Papillomavirus Infections
Acyclovir
Neonatal herpes
Central Nervous System Diseases
Drug Resistance
Disease Outbreaks
Mucous Membrane

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Pinninti, S. G., Angara, R., Feja, K. N., Kimberlin, D. W., Leach, C. T., Conrad, D. A., ... Tolan, R. W. (2012). Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: A multicenter case series. Journal of Pediatrics, 161(1). https://doi.org/10.1016/j.jpeds.2011.12.053

Neonatal herpes disease following maternal antenatal antiviral suppressive therapy : A multicenter case series. / Pinninti, Swetha G; Angara, Radhika; Feja, Kristina N.; Kimberlin, David W.; Leach, Charles T.; Conrad, Dennis A.; McCarthy, Carol A.; Tolan, Robert W.

In: Journal of Pediatrics, Vol. 161, No. 1, 01.01.2012.

Research output: Contribution to journalArticle

Pinninti, SG, Angara, R, Feja, KN, Kimberlin, DW, Leach, CT, Conrad, DA, McCarthy, CA & Tolan, RW 2012, 'Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: A multicenter case series', Journal of Pediatrics, vol. 161, no. 1. https://doi.org/10.1016/j.jpeds.2011.12.053
Pinninti, Swetha G ; Angara, Radhika ; Feja, Kristina N. ; Kimberlin, David W. ; Leach, Charles T. ; Conrad, Dennis A. ; McCarthy, Carol A. ; Tolan, Robert W. / Neonatal herpes disease following maternal antenatal antiviral suppressive therapy : A multicenter case series. In: Journal of Pediatrics. 2012 ; Vol. 161, No. 1.
@article{505781d3431b48b890745098f611f2ea,
title = "Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: A multicenter case series",
abstract = "Objective: The goal was to describe herpes simplex virus (HSV) disease in neonates whose mothers received suppressive acyclovir therapy for HSV infection. Study design: A multicenter case series of 8 infants who developed neonatal HSV disease following maternal antiviral suppressive therapy during pregnancy. Results: Eight infants were identified from New Jersey (5), Maine (1), New York (1), and Texas (1) between 2005 and 2009. All 6 mothers of infants infected with HSV who were screened prenatally for group B Streptococcus were positive; 1 mother was not tested and the other had bacterial vaginosis and genital human papillomavirus infection. Six mothers had a first clinical episode of genital HSV infection during this pregnancy; mothers with a prior history of genital HSV had no clinically recognized outbreak during the pregnancy. Perinatal transmission of HSV occurred in 7 infants (despite suppressive therapy until the day of delivery in 5 instances). Seven of 8 patients were born at term; 6 infants were male. In 7 of 8 cases, HSV was diagnosed by 8 days of age. Five infants had skin, eye, and mucous membrane disease, 2 had central nervous system disease (without and with disseminated disease), and one had intrauterine/disseminated disease. Conclusions: Although maternal antiviral suppressive therapy is an increasingly wide practice, physicians caring for neonates should be aware that suppressive therapy does not prevent neonatal HSV disease, which can have an atypical clinical presentation and drug resistance.",
author = "Pinninti, {Swetha G} and Radhika Angara and Feja, {Kristina N.} and Kimberlin, {David W.} and Leach, {Charles T.} and Conrad, {Dennis A.} and McCarthy, {Carol A.} and Tolan, {Robert W.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/j.jpeds.2011.12.053",
language = "English (US)",
volume = "161",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Neonatal herpes disease following maternal antenatal antiviral suppressive therapy

T2 - A multicenter case series

AU - Pinninti, Swetha G

AU - Angara, Radhika

AU - Feja, Kristina N.

AU - Kimberlin, David W.

AU - Leach, Charles T.

AU - Conrad, Dennis A.

AU - McCarthy, Carol A.

AU - Tolan, Robert W.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Objective: The goal was to describe herpes simplex virus (HSV) disease in neonates whose mothers received suppressive acyclovir therapy for HSV infection. Study design: A multicenter case series of 8 infants who developed neonatal HSV disease following maternal antiviral suppressive therapy during pregnancy. Results: Eight infants were identified from New Jersey (5), Maine (1), New York (1), and Texas (1) between 2005 and 2009. All 6 mothers of infants infected with HSV who were screened prenatally for group B Streptococcus were positive; 1 mother was not tested and the other had bacterial vaginosis and genital human papillomavirus infection. Six mothers had a first clinical episode of genital HSV infection during this pregnancy; mothers with a prior history of genital HSV had no clinically recognized outbreak during the pregnancy. Perinatal transmission of HSV occurred in 7 infants (despite suppressive therapy until the day of delivery in 5 instances). Seven of 8 patients were born at term; 6 infants were male. In 7 of 8 cases, HSV was diagnosed by 8 days of age. Five infants had skin, eye, and mucous membrane disease, 2 had central nervous system disease (without and with disseminated disease), and one had intrauterine/disseminated disease. Conclusions: Although maternal antiviral suppressive therapy is an increasingly wide practice, physicians caring for neonates should be aware that suppressive therapy does not prevent neonatal HSV disease, which can have an atypical clinical presentation and drug resistance.

AB - Objective: The goal was to describe herpes simplex virus (HSV) disease in neonates whose mothers received suppressive acyclovir therapy for HSV infection. Study design: A multicenter case series of 8 infants who developed neonatal HSV disease following maternal antiviral suppressive therapy during pregnancy. Results: Eight infants were identified from New Jersey (5), Maine (1), New York (1), and Texas (1) between 2005 and 2009. All 6 mothers of infants infected with HSV who were screened prenatally for group B Streptococcus were positive; 1 mother was not tested and the other had bacterial vaginosis and genital human papillomavirus infection. Six mothers had a first clinical episode of genital HSV infection during this pregnancy; mothers with a prior history of genital HSV had no clinically recognized outbreak during the pregnancy. Perinatal transmission of HSV occurred in 7 infants (despite suppressive therapy until the day of delivery in 5 instances). Seven of 8 patients were born at term; 6 infants were male. In 7 of 8 cases, HSV was diagnosed by 8 days of age. Five infants had skin, eye, and mucous membrane disease, 2 had central nervous system disease (without and with disseminated disease), and one had intrauterine/disseminated disease. Conclusions: Although maternal antiviral suppressive therapy is an increasingly wide practice, physicians caring for neonates should be aware that suppressive therapy does not prevent neonatal HSV disease, which can have an atypical clinical presentation and drug resistance.

UR - http://www.scopus.com/inward/record.url?scp=84862753453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862753453&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2011.12.053

DO - 10.1016/j.jpeds.2011.12.053

M3 - Article

VL - 161

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 1

ER -